This website uses cookies to enhance the user experience.
O

ORIPATCH AS923 723 854

Process industry
Limited company
Høvågveien 220 4639 KRISTIANSAND S, Norge

ORIPATCH AS

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

Chairman of the board
Years since formation
6 years
since Oct 30, 2019
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
37,500
1 share class
Total number of shareholders
4
companies
Belongs to group of

Financials

Total operating income 2024
1,018,000
NOK
Annual total result 2024
-1,520,534
NOK
Total equity 2024
81,221
NOK
Last update: May 7, 2025

Management

Board

NameRoleShares
Chairman
29.4 %
indirectly
Board Member
30.6 %
indirectly
Board Member
20 %
indirectly
Board Member
3.3 %
indirectly

Others

NameRoleShares
A
AZETS INSIGHT AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Board Member
30.6 %
indirectly
Chairman
29.4 %
indirectly
Board Member
20 %
indirectly
-
6.89 %
indirectly
-
3.3 %
indirectly
Board Member
3.3 %
indirectly
-
3.3 %
indirectly
SE
-
3.2 %
indirectly
Last update: Sep 30, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
S
SKUTHE HOLDING AS
Ordinary shares
22,500
60 %
S
SKABE AS
Ordinary shares
7,500
20 %
T
TVEDT & CO AS
Ordinary shares
6,300
16.8 %
Q
QUAESTOR FORVALTNING AS
Ordinary shares
1,200
3.2 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -8,091
    Employees: 0

Financials

in NOK

Summary

Year202420232022
Total operating income
1,018,000
1,028,368
575,991
Annual Total Result
-1,520,534
-577,227
-636,659
Total assets
694,565
1,698,847
2,429,923
Total liabilities
613,343
97,092
250,940
Total equity
81,221
1,601,755
2,178,983

P&L

Year202420232022
Total operating income
1,018,000
1,028,368
575,991
Total operating costs
2,542,946
1,350,577
1,400,407
Operating result
-1,524,946
-322,209
-824,416
Financial income/costs
4,412
-14,989
8,187
Profit before tax
-1,520,534
-337,197
-816,229
Total tax & extraordinary income/cost
0
240,030
-179,570
Annual Total Result
-1,520,534
-577,227
-636,659

Balance overview

Year202420232022
Total fixed assets
0
0
240,030
Total current assets
694,565
1,698,847
2,189,893
Total assets
694,565
1,698,847
2,429,923
Short term debt
113,343
97,092
250,940
Long term debt
500,000
0
0
Total liabilities
613,343
97,092
250,940
Contributed capital
81,221
1,601,755
3,024,430
Retained earnings
0
0
-845,447
Total equity
81,221
1,601,755
2,178,983
Total equity and liabilities
694,565
1,698,847
2,429,923

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations